Q32 Bio's market cap is currently $29.60M. The company's EPS TTM is $-14.205; its P/E ratio is ―; Q32 Bio is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.16M	$ 6.65M	$ 33.97M	$ 2.70M	$ 1.67M
Gross Profit	$ 578.00K	$ 4.05M	$ 24.43M	$ 2.70M	$ 1.67M
Operating Income	$ -92.10M	$ -39.23M	$ -36.69M	$ -130.26M	$ -109.94M
EBITDA	$ -86.50M	$ -38.85M	$ -86.22M	$ -121.36M	$ -103.63M
Net Income	$ -112.96M	$ -42.81M	$ -37.56M	$ -128.69M	$ -103.92M
Balance Sheet
Cash & Short-Term Investments	$ 82.65M	$ 43.89M	$ 32.25M	$ 217.43M	$ 262.39M
Total Assets	$ 306.12M	$ 61.77M	$ 35.15M	$ 263.74M	$ 310.57M
Total Debt	$ 1.32M	$ 44.73M	$ 4.97M	$ 15.44M	$ 0.00
Net Debt	$ -37.95M	$ 838.00K	$ -27.27M	$ -201.99M	$ -53.77M
Total Liabilities	$ 233.13M	$ 192.49M	$ 124.36M	$ 67.74M	$ 52.06M
Stockholders' Equity	$ 72.99M	$ -130.71M	$ -89.21M	$ 196.00M	$ 258.51M
Cash Flow
Free Cash Flow	$ -96.46M	$ -13.44M	$ -33.14M	$ -98.06M	$ -113.19M
Operating Cash Flow	$ -96.23M	$ -10.96M	$ -32.98M	$ -94.33M	$ -91.36M
Investing Cash Flow	$ 101.33M	$ -2.47M	$ -157.00K	$ 204.90M	$ -51.80M
Financing Cash Flow	$ 184.00K	$ 30.07M	$ 20.11M	$ 53.09M	$ 158.21M

Currency in USD

Q32 Bio Earnings and Revenue History

Income Statement >

Q32 Bio Debt to Assets

Balance Sheet >

Q32 Bio Cash Flow

Cash Flow >

Q32 Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing